HDAC6 and breast carcinoma: Low Cry2 acetylation level showed a stronger inhibition of breast cancer cell growth, which inhibited by HDAC6, consistent with a previous report showing that high HDAC6 expression was associated with higher survival in breast cancer patients [34].